Benzinga | May 10, 2021 08:37AM EDT

Aeglea BioTherapeutics Q1 EPS $(0.28) Up From $(0.57) YoY

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.28) per share. This is a 50.88 percent increase over losses of $(0.57) per share from the same period last year.